Sjögren, Hannah
Pahlm, Ulrika
Engblom, Henrik
Erlinge, David
Heiberg, Einar
Arheden, Håkan
Carlsson, Marcus
Ostenfeld, Ellen http://orcid.org/0000-0002-2655-2423
Funding for this research was provided by:
Vetenskapsrådet
Hjärt-Lungfonden
Lunds Universitet
Region Skåne
Southern Healthcare Region of Sweden
Wallenberg Centre for Molecular Medicine
Crafoordska Stiftelsen
Skånes universitetssjukhus
Lund University
Article History
Received: 7 April 2021
Accepted: 21 August 2021
First Online: 5 September 2021
Declarations
:
: MC, EH, HE and HA received consultancy fees from Imacor AB for cardiac MRI analysis in the CHILL-MI trial. HA is stock owner of Imacor AB. EH is owner of Medviso AB producing software for cardiac image analysis. Otherwise, the authors declare that they have no conflict of interest.
: Written informed consent was obtained from all subjects in the original study. The Regional Ethical Review Board in Lund, Sweden, approved the CHILL-MI study and permission from local ethical review boards was granted at each centre.
: Not applicable.